Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Lowered to $240 at Cantor Fitzgerald on Bad Sentiment

April 8, 2026 7:31 AM
Cantor Fitzgerald analyst Carter Gould lowered the price target on Abbvie (NYSE: ABBV) to $240.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change